Sandoz Pharmaceuticals AG - Omnitrope 15 mg, Injektionslösung |
| 61306 | | 03 | | Omnitrope 15 mg | | Injektionslösung | | H01AC01 | | Somatropin | | 01.09.2014 | | |
|
Composition |
somatropinum ADNr 15.0 mg corresp. 45 U.I., dinatrii phosphas heptahydricus, natrii dihydrogenophosphas dihydricus, poloxamerum 188, phenolum, natrii chloridum, acidum phosphoricum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 1.50 ml corresp. natrium 4.70 mg. |
Packungsbestandteile |
| Injection solution | | | | | | Active Agent | Dose |
---|
Somatropinum Adnr | 15 mg |
| BAG: Active Agent | Dose |
---|
Somatropinum Adnr | 15 mg |
| | Inactive agents | Dose |
---|
Phosphoric Acid | | Disodium Phosphate Heptahydrate | | Sodium Chloride | | Sodium Dihydrogenophosphate Dihydrate | | Sodium Hydroxide | | Phenol | | Poloxamer | 188 |
| |
|
|